Communicate with Supplier? Supplier
Kelly Ms. Kelly
What can I do for you?
Chat Now
Chat Now Contact Supplier

 Shandong Haohong Biotechnology Co., Ltd.

  • All
  • Title
  • All
  • Title
Home Tags
Main Tags
Crpc Intermediate Cas 654-70-6 Crpc Drug Intermediate Cas 403-24-7 Pharma Intermedaite Cas 915087-25-1 Apalutamide Intermediates prostate cancer Apalutamide Cas 915087-25-1 Apalutamide Cas 403-24-7 Apalutamide Cas No 403-24-7 Apalutamide Intermediates 573762-62-6 Enzalutamide Intermediate Cas No 143782-23-4 Enzalutamide Project Cas 143782-23-4 Enzalutamide Cas 915087-24-0 Enzalutamide Cas 609784-45-4 Anti Diabetic Drugs Antidiabetic Drug Classes Antidiabetic Drug List Empagliflozin Intermediates Empagliflozin Cas 915095-89-5 Empagliflozin Cas 915095-86-2 Empagliflozin Cas 915095-84-0 Empagliflozin Cas 915095-85-1 Anticancer Drug Classification Anticancer Drug List Cabozantinib Intermediates Alectinib Intermediates Ceritinib Intermediates Larotrectinib Intermediates Ponatinib Intermediates Ruxolitinib Intermediates Anticancer Drug Development Alectinib Cas 1247119-83-0 Alectinib Cas 1256578-99-0 Alectinib Cas 1256584-80-1 Alectinib Cas 1256584-75-4 Cabozantinib Cas 13425-93-9 Cabozantinib Cas 35654-56-9 Cabozantinib Cas 190728-25-7 Cabozantinib Cas 598-10-7 Ceritinib Cas 76697-50-2 Ceritinib Cas 1202858-68-1 Ceritinib Cas 1032903-63-1 Ceritinib Cas 761440-16-8 Larotrectinib Cas 1223404-89-4 Larotrectinib Cas 1218935-59-1 Larotrectinib Cas 29274-22-4 Larotrectinib Cas 29274-24-6 Brigatinib Cas 1197953-49-3 Brigatinib Cas 761440-75-9 Brigatinib Cas 53617-36-0 Brigatinib Intermediate Cas 1197953-49-3 Abemaciclib Cas 1180132-17-5 Abemaciclib Cas 1231930-42-9 Abemaciclib Cas 1231930-37-2 Abemaciclib Cas 67567-26-4 Vemurafenib Cas 1103234-56-5 Vemurafenib Cas 183208-35-7 Vemurafenib Cas 918516-27-5 Vemurafenib Cas 84832-02-0 Ponatinib Cas 694499-24-6 Ponatinib Cas 18087-73-5 Ponatinib Cas 943320-50-1 Ponatinib Cas 943320-61-4 Rucaparib Cas 78902-09-7 Rucaparib Cas 2913-97-5 Rucaparib Intermediate Cas 78902-09-7 Rucaparib Intermediate Cas 2913-97-5 Rheumatoid Arthritis Ra Drug Tofacitinib Intermediates CAS 3680-69-1 Baricitinib Intermediates Cas 2075-45-8 Baricitinib Intermediates Cas 269410-08-4 Upadacitinib Intermediates Tofacitinib Intermediate Cas 3680-69-1 Tofacitinib Cas 3680-69-1 Tofacitinib Intermediate Preparation Intermediates Of Tofacitinib;rheumatoid arthritis (RA) Cabozantinib Api Cabozantinib Malate Ceritinib Api Enzalutamide API Apalutamide API Baricitinib API Active Pharmaceutical Ingredients - Fda Enzalutamide Api Enzalutamide & Apalutamide Projects Bicalutamide Enzalutamide And Apalutamide Enzalutamide Api And Intermediates Apalutamide Api Apalutamide Api Project Apalutamide Cas 956104-40-8 Apalutamice Inn Arn-509 Cabozantinib Xl184 Malate 14C Cabozantinib Api Cabozantinib Xl184 Bms-907351 Cabozantinib Cas 849217-68-1 Alecitinib Api Alectinib Cas 1256589-74-8 Alectinib Hydrochloride Unii-P9Yy73Lo6J Alectinib Api Cas 1256589-74-8 Ceritinib Cas 1032900-25-6 Ceritinib Project 1032900-25-6 Ceritinib Dihydrochloride Cas 1380575-43-8 Ceritinib Project Cs-1407 Bicalutamide Intermediate Bicalutamide Intermediate Cas No.654-70-6 Bicalutamdie Intermediate Cas 90357-53-2 Bicalutamdie Intermediate Cas 654-70-6 Tofacitinib Api Tofacitinib Cas 540737-29-9 Tofacitinib Citrate Project Tofacitinib Api Cas 540737-29-9 Pah Drugs In Development Actelion Pah Drugs List Of Pah Drugs Approved Pah Drugs Macitentan Intermediate 146533-41-7 Macitentan Intermediate 706811-25-8 Macitentan Intermediate 147962-41-2 Macitentan Intermediate 1393813-41-6 Macitentan Api Macitentan Cas 441798-33-0 Macitentan Actelion-1 Opsumit Macitentan Api Project Actelion-1 Ponatinib Api Ponatinib Cas 943319-70-8 Ap24534 Ponatinib Cs-165 Iclusig Ponatinib Api Larotrectinib Api Larotrectinib Cas 1223403-58-4 Larotrectinib Free Base Larotrectinib Loxo-101 Arry-470 Lenvatinib Cas 417721-36-9 Lenvatinib Cas 796848-79-8 Lenvatinib Cas 52671-64-4 Lenvatinib Cas 17609-80-2 Vemurafenib Api Vemurafenib Cas 1029872-54-5 Vemurafenib Api Cas 1029872-54-5 Vemurafenib Indications Gilteritinib Cas 1254058-34-8 Gilteritinib Cas 2043020-03-5 Gilteritinib Cas 454-16-0 Gilteritinib Cas 33024-60-1 Upadacitinib Cas 1201187-44-1 Upadacitinib Cas 1428243-26-8 Upadacitinib Intermediate Cas 1201187-44-1 Upadacitinib Intermediate Cas 1428243-26-8 Migraine Drug Of Choice Rimegepant Intermediate Cas 1190363-46-2 Rimegepant Intermediate Cas 1373116-06-3 Rimegepant Intermediates Rimegepant Cas 1190363-46-2 Rimegepant Cas 1373116-06-3 Rimegepant Cas 1190363-45-1 Gilteritinib Api Gilteritinib Cas 1254053-43-4 Gilteritinib Asp2215 2 Pyrazinecarboxamide Gilteritinib Api Cas 1254053-43-4 Empagliflozin; 864070-44-0; JARDIANCE; BI 10773; Empagliflozin (BI 10773); Pomalidomide; 19171-19-8; 4-Amino-2-(2 6-Dioxopiperidin-3-Yl)Isoindoline-1 3-Dione; Actimid; CC-4047; Pomalyst; Imnovid; Ruxolitinib; 941678-49-5; INCB018424; Ruxolitinib (INCB018424); (R)-3-(4-(7H-Pyrrolo[2 3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile; INCB-018424; INCB 018424; UNII-82S8X8XX8H; Baricitinib; 1187594-09-7; INCB028050; LY3009104; 2-(3-(4-(7H-Pyrrolo[2 3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-1-(Ethylsulfonyl)Azetidin-3-Yl)Acetonitrile; INCB 028050; Regorafenib; 755037-03-7; BAY 73-4506; Stivarga; 4-(4-(3-(4-Chloro-3-(Trifluoromethyl)Phenyl)Ureido)-3-Fluorophenoxy)-N-Methylpicolinamide; Regorafenibum; Palbociclib; 571190-30-2; PD0332991; PD-0332991; Ibrance; PD 0332991; UNII-G9ZF61LE7G; Regorafenib Monohydrate CAS 1019206-88-2 Anticoagulant Drug Rivaroxaban Intermediate Cas 438056-69-0 Rivaroxaban Intermediate Cas 161596-47-0 Rivaroxaban Intermediate Cas 898543-06-1 Apixaban Intermediate Cas 38560-30-4 etc. BASIC RAW MATERIAL Pharmaceutial intermediates Fine chemicals General reagent




About Us